Core Laboratories (CLB) Equity Ratio (2022 - 2026)

Core Laboratories has reported Equity Ratio for 5 years, with the latest figure at 0.47 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio rose 8.08% year-over-year to 0.47; the trailing twelve-month figure through Mar 2026 stood at 0.47 (up 8.08% YoY), and the FY2025 full-year result was 0.46, up 5.62% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.47, up from 0.46 in the prior quarter.
• The five-year high for Equity Ratio was 0.47 in Q1 2026, with the low at 0.3 in Q2 2022.
• Historically, Equity Ratio has averaged 0.4 across 5 years, with a median of 0.4 in 2024.
• Annual changes were most pronounced in 2023 — Equity Ratio climbed 21.27% — and 2025, when it advanced 5.62%.
• Core Laboratories' Equity Ratio stood at 0.32 in 2022, then rose by 20.58% to 0.38 in 2023, then gained by 12.69% to 0.43 in 2024, then rose by 5.62% to 0.46 in 2025, then grew by 2.79% to 0.47 in 2026.
• The last three Equity Ratio figures came in at 0.47 (Q1 2026), 0.46 (Q4 2025), and 0.46 (Q3 2025), per Business Quant data.